South Korea vs North Macedonia: Tuberculosis treatment success rate by type
South Korea
79
in 2023
North Macedonia
79
in 2023
South Korea rank
120th
North Macedonia rank
120th
Tuberculosis treatment success rate by type over time
- South Korea
- North Macedonia
How they compare
South Korea currently reports 79 against 79 in North Macedonia, a difference of 0.
The two have swapped places 9 times across 27 shared years of data; in 1995 it was South Korea ahead.
South Korea ranks 120th and North Macedonia ranks 120th of 194 countries.
Across the 4 decades both report, South Korea averaged higher in 1 and North Macedonia in 3.
Head to head by decade
| Decade | South Korea | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 76.33 | 77.67 | 1.33 | North Macedonia |
| 2000s | 82.3 | 84.8 | 2.5 | North Macedonia |
| 2010s | 83.3 | 87.6 | 4.3 | North Macedonia |
| 2020s | 79.75 | 77.25 | 2.5 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, South Korea or North Macedonia?
- South Korea, at 79 against 79 in North Macedonia as of 2023.
- What is the difference in tuberculosis treatment success rate by type between South Korea and North Macedonia?
- 0, with South Korea ahead.
- How many years of comparable data are there for South Korea and North Macedonia?
- 27 years are reported by both, from 1995 to 2023.
- How do South Korea and North Macedonia rank globally for tuberculosis treatment success rate by type?
- South Korea ranks 120th and North Macedonia ranks 120th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.